Non-inferiority Trial Comparing Insulin Glulisine to Insulin Lispro as Part of a Basal-bolus Insulin Regimen for the Treatment of Gestational Diabetes.

Trial Profile

Non-inferiority Trial Comparing Insulin Glulisine to Insulin Lispro as Part of a Basal-bolus Insulin Regimen for the Treatment of Gestational Diabetes.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 16 Nov 2017

At a glance

  • Drugs Insulin glulisine (Primary) ; Insulin; Insulin lispro
  • Indications Gestational diabetes; Hyperglycaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 May 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
    • 06 May 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
    • 21 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top